A COST EFFECTIVENESS ANALYSIS OF NIVOLUMAB COMPARED WITH PEMETREXED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN REAL PRACTICE

A COST EFFECTIVENESS ANALYSIS OF NIVOLUMAB COMPARED WITH PEMETREXED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER IN REAL PRACTICE